Gates Foundation awards $800K grant to A-Alpha Bio for COVID-19 treatment research
- July 9, 2020
Seattle-based biotech research startup A-Alpha Bio has received an $800,000 grant from the Bill & Melinda Gates Foundation that will support drug research for treating infectious diseases, including respiratory viruses such as the novel coronavirus as well as intestinal pathogens.